Magnetic resonance and near-infrared imaging using a novel dual-modality nano-probe for dendritic cell tracking in vivo

Cytotherapy

Volumn 16, Issue 5, 2014, Pages 699-710

  Chen, Yu Chen ^a   Wen, Song ^a   Shang, Song An ^a   Cui, Ying ^a   Luo, Bing ^a   Teng, Gao Jun ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Dendritic cell; Dual modality; Immunotherapy; Migration

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; FLUORESCENT DYE; FLUORESCENT DYE NIR797; GLYCOPROTEIN P 15095; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CELL HOMING; CELL ISOLATION; CELL LABELING; CELL MATURATION; CELL MIGRATION; CELL TRACKING; CELLULAR DISTRIBUTION; COCULTURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTING; FOOT PAD; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIXED LYMPHOCYTE REACTION; MOLECULAR IMAGING; MOUSE; NANOPROBE; NEAR INFRARED IMAGING SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; T LYMPHOCYTE ACTIVATION; ANIMAL; CELL CULTURE; IMMUNOTHERAPY; PROCEDURES;

MUS;

ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; IMMUNOTHERAPY; MAGNETIC RESONANCE IMAGING; MICE;

EID: 84897960718     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2013.09.006     Document Type: Article

References (41)

1. Figdor C.G., De Vries I.J.M., Lesterhuis W.J., Melief C.J.M. Dendritic cell immunotherapy: mapping the way. Nat Med 2004, 10:475-480.
2. O'Neill D.W., Adams S., Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood 2004, 104:2235-2246.
3. Palucka K., Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer 2012, 12:265-277.
4. Schwarz S., Wong J.E., Bornemann J., Hodenius M., Himmelreich U., Richtering W., et al. Polyelectrolyte coating of iron oxide nanoparticles for MRI-based cell tracking. Nanomedicine 2012, 8:682-691.
5. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat Rev Immunol 2005, 5:296-306.
6. Tel J., de Vries I. Potential applications for plasmacytoid dendritic cells in cancer immunotherapy. Immunotherapy 2012, 4:979.
7. Stroncek D., Berlyne D., Fox B., Gee A., Heimfeld S., Lindblad R., et al. Developments in clinical cell therapy. Cytotherapy 2010, 12:425-428.
8. Comes Franchini M., Baldi G., Bonacchi D., Gentili D., Giudetti G., Lascialfari A., et al. Bovine serum albumin-based magnetic nanocarrier for MRI diagnosis and hyperthermic therapy: a potential theranostic approach against cancer. Small 2010, 6:366-370.
9. Chen J., Jia Z.Y., Ma Z.L., Wang Y.Y., Teng G.J. In vivo serial MR imaging of magnetically labeled endothelial progenitor cells homing to the endothelium injured artery in mice. PloS One 2011, 6:e20790.
10. Mai X.L., Ma Z.L., Sun J.H., Ju S.H., Ma M., Teng G.J. Assessments of proliferation capacity and viability of New Zealand rabbit peripheral blood endothelial progenitor cells labeled with superparamagnetic particles. Cell Transplant 2009, 18:171-181.
11. Weissleder R., Stark D., Engelstad B., Bacon B., Compton C., White D., et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR Am J Roentgenol 1989, 152:167-173.
12. Sun J.H., Teng G.J., Ju S.H., Ma Z.L., Mai X.L., Ma M. MR tracking of magnetically labeled mesenchymal stem cells in rat kidneys with acute renal failure. Cell Transplant 2008, 17:279-290.
13. Long C.M., van Laarhoven H.W.M., Bulte J.W.M., Levitsky H.I. Magnetovaccination as a novel method to assess and quantify dendritic cell tumor antigen capture and delivery to lymph nodes. Cancer Res 2009, 69:3180-3187.
14. Kobukai S., Baheza R., Cobb J.G., Virostko J., Xie J., Gillman A., et al. Magnetic nanoparticles for imaging dendritic cells. Magn Reson Med 2010, 63:1383-1390.
15. Mou Y., Hou Y., Chen B., Hua Z., Zhang Y., Xie H., et al. In vivo migration of dendritic cells labeled with synthetic superparamagnetic iron oxide. Int J Nanomed 2011, 6:2633.
16. de Vries I.J.M., Lesterhuis W.J., Barentsz J.O., Verdijk P., van Krieken J.H., Boerman O.C., et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005, 23:1407-1413.
17. He X., Gao J., Gambhir S.S., Cheng Z. Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends Mol Med 2010, 16:574-583.
18. Kosaka N., McCann T.E., Mitsunaga M., Choyke P.L., Kobayashi H. Real-time optical imaging using quantum dot and related nanocrystals. Nanomedicine 2010, 5:765-776.
19. Christian N.A., Benencia F., Milone M.C., Li G., Frail P.R., Therien M.J., et al. In vivo dendritic cell tracking using fluorescence lifetime imaging and near-infrared-emissive polymersomes. Mol Imaging Biol 2009, 11:167-177.
20. Cao A.H., Shi H.J., Zhang Y., Teng G.J. In vivo tracking of dual-labeled mesenchymal stem cells homing into the injured common carotid artery. Anat Rec 2009, 292:1677-1683.
21. Kosaka N., Bernardo M., Mitsunaga M., Choyke P.L., Kobayashi H. MR and optical imaging of early micrometastases in lymph nodes: triple labeling with nano-sized agents yielding distinct signals. Contrast Media Mol Imaging 2012, 7:247-253.
22. Zhang T., Ge J., Hu Y., Yin Y. Ageneral approach for transferring hydrophobic nanocrystals into water. Nano Lett 2007, 7:3203-3207.
23. Liu D., Wu W., Ling J., Wen S., Gu N., Zhang X. Effective PEGylation of iron oxide nanoparticles for high performance in vivo cancer imaging. Advanced Functional Materials 2011, 21:1498-1504.
24. Xie H., Hua C., Sun L., Zhao X., Fan H., Dou H., et al. 17β-estradiol induces CD40 expression in dendritic cells via MAPK signaling pathways in a minichromosome maintenance protein 6-dependent manner. Arthritis Rheum 2011, 63:2425-2435.
25. Martín-Fontecha A., Sebastiani S., Höpken U.E., Uguccioni M., Lipp M., Lanzavecchia A., et al. Regulation of dendritic cell migration to the draining lymph node impact on T lymphocyte traffic and priming. JExp Med 2003, 198:615-621.
26. Dekaban G.A., Snir J., Shrum B., de Chickera S., Willert C., Merrill M., et al. Semiquantitation of mouse dendritic cell migration in vivo using cellular MRI. JImmunother 2009, 32:240-251.
27. Steinman R.M., Banchereau J. Taking dendritic cells into medicine. Nature 2007, 449:419-426.
28. Steinman R.M. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 2012, 30:1-22.
29. Chen R., Yu H., Jia Z.Y., Yao Q.L., Teng G.J. Efficient nano iron particle-labeling and noninvasive MR imaging of mouse bone marrow-derived endothelial progenitor cells. Int J Nanomed 2011, 6:511.
30. Malmsten M., Bysell H., Hansson P. Biomacromolecules in microgels-opportunities and challenges for drug delivery. Curr Opin Colloid Interface Sci 2010, 15:435-444.
31. Mackay P.S., Kremers G.J., Kobukai S., Cobb J.G., Kuley A., Rosenthal S.J., et al. Multimodal imaging of dendritic cells using a novel hybrid magneto-optical nanoprobe. Nanomedicine 2011, 7:489-496.
32. Yong K.T., Law W.C., Hu R., Ye L., Liu L., Swihart M.T., et al. Nanotoxicity assessment of quantum dots: from cellular to primate studies. Chem Soc Rev 2013, 42:1236-1250.
33. Rohani R., de Chickera S.N., Willert C., Chen Y., Dekaban G.A., Foster P.J. In vivo cellular MRI of dendritic cell migration using micrometer-sized iron oxide (MPIO) particles. Mol Imaging Biol 2011, 13:679-694.
34. Noh Y.W., Jang Y.S., Ahn K.J., Lim Y.T., Chung B.H. Simultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response. Biomaterials 2011, 32:6254-6263.
35. Pham W., Xie J., Gore J.C. Tracking the migration of dendritic cells by in vivo optical imaging. Neoplasia (New York, NY) 2007, 9:1130.
36. Noh Y.W., Lim Y.T., Chung B.H. Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent semiconductor nanocrystals. FASEB J 2008, 22:3908-3918.
37. Szakal A., Holmes K., Tew J. Transport of immune complexes from the subcapsular sinus to lymph node follicles on the surface of nonphagocytic cells, including cells with dendritic morphology. JImmunol 1983, 131:1714-1727.
38. Eggert A.A.O., van der Voort R., Torensma R., Moulin V., Boerman O.C., Oyen W.J.G., et al. Analysis of dendritic cell trafficking using EGFP-transgenic mice. Immunol Lett 2003, 89:17-24.
39. Aarntzen E.H., Srinivas M., Bonetto F., Cruz L.J., Verdijk P., Schreibelt G., et al. Targeting of 111In-labeled dendritic cell human vaccines improved by reducing number of cells. Clin Cancer Res 2013, 19:1525-1533.
40. Verdijk P., Aarntzen E.H., Lesterhuis W.J., Boullart A.I., Kok E., van Rossum M.M., et al. Limited amounts of dendritic cells migrate into the T-cell area of lymph nodes but have high immune activating potential in melanoma patients. Clin Cancer Res 2009, 15:2531-2540.
41. Angeli V., Randolph G.J. Inflammation, lymphatic function, and dendritic cell migration. Lymphat Res Biol 2006, 4:217-228.